ENXTPA:DIMLife Sciences
Assessing Sartorius Stedim Biotech (ENXTPA:DIM) Valuation After Full Year 2025 Results And Improved Profitability
Sartorius Stedim Biotech (ENXTPA:DIM) just released full year 2025 results, reporting sales of €2,967.5m and net income of €265.6m. This development is putting recent share performance into focus.
See our latest analysis for Sartorius Stedim Biotech.
At a share price of €183.1, Sartorius Stedim Biotech has seen a 3.62% 7-day share price return, but the 1-year total shareholder return of a 6.75% decline and 3-year total shareholder return of a 40.73% decline point to fading longer-term...